These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 341110)

  • 41. Clomipramine in obsessive-compulsive ritualisers treated with exposure therapy: relations between dose, plasma levels, outcome and side effects.
    Kasvikis Y; Marks IM
    Psychopharmacology (Berl); 1988; 95(1):113-8. PubMed ID: 3133689
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clomipramine in the treatment of obsessive-compulsive neuroses].
    Hartelius H
    Lakartidningen; 1975 Mar; 72(10):973. PubMed ID: 1128031
    [No Abstract]   [Full Text] [Related]  

  • 43. Changes in obsessive/compulsive patients as measured by the Leyton Inventory before and after treatment with clomipramine.
    Allen JJ; Rack PH
    Scott Med J; 1975; 20(1 SUPPL):41-4. PubMed ID: 1098144
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Analysis of controlled studies comparing mianserin and clomipramine (author's transl)].
    de Buck RP
    Encephale; 1981; 7(4 Suppl):455-72. PubMed ID: 7032887
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clomipramine for obsessive compulsive disorder.
    Med Lett Drugs Ther; 1988 Nov; 30(778):102-4. PubMed ID: 3050411
    [No Abstract]   [Full Text] [Related]  

  • 46. Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorder.
    Hewlett WA; Vinogradov S; Agras WS
    J Clin Psychopharmacol; 1992 Dec; 12(6):420-30. PubMed ID: 1474179
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A controlled trial of clomipramine in childhood obsessive compulsive disorder.
    Flament MF; Rapoport JL; Kilts C
    Psychopharmacol Bull; 1985; 21(1):150-2. PubMed ID: 3885292
    [No Abstract]   [Full Text] [Related]  

  • 48. A double-blind comparison of lofepramine and clomipramine in depressed outpatients.
    Dimitriou E; Paraschos A; Logothetis J
    Psychopharmacol Bull; 1984; 20(4):684-7. PubMed ID: 6387760
    [No Abstract]   [Full Text] [Related]  

  • 49. Clomipramine demethylation rate is important on the outcome of obsessive-compulsive disorder treatment.
    Marcourakis T; Bernik MA; Lotufo Neto F; Gedanke Shavitt R; Gorenstein C
    Int Clin Psychopharmacol; 2015 Jan; 30(1):43-8. PubMed ID: 25279584
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder.
    Pato MT; Zohar-Kadouch R; Zohar J; Murphy DL
    Am J Psychiatry; 1988 Dec; 145(12):1521-5. PubMed ID: 3057923
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proceedings: Systematic clinical studies with clomipramine in depressed psychiatric patients--III. Standard-controlled clinical trial.
    Pecknold JC; Gratton L; Ban TA; Klingner A
    Psychopharmacol Bull; 1976 Jan; 12(1):26-7. PubMed ID: 1108079
    [No Abstract]   [Full Text] [Related]  

  • 52. Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients.
    Jenike MA; Baer L; Summergrad P; Weilburg JB; Holland A; Seymour R
    Am J Psychiatry; 1989 Oct; 146(10):1328-30. PubMed ID: 2675643
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical experience in the treatment of obsessional states (2).
    Rack PH
    J Int Med Res; 1977; 5 Suppl 5():81-90. PubMed ID: 598609
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Worldwide use of clomipramine.
    Trimble MR
    J Clin Psychiatry; 1990 Aug; 51 Suppl():51-4; discussion 55-8. PubMed ID: 2199435
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The use of clomipramine in phobic patients. Preliminary research report.
    Carey MS; Hawkinson R; Kornhaber A; Wellish CS
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):107-10. PubMed ID: 806423
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical controlled trial of chlorimipramine in adolescents with obsessive-compulsive disorder.
    Rapoport J; Elkins R; Mikkelsen E
    Psychopharmacol Bull; 1980 Jul; 16(3):61-3. PubMed ID: 6996027
    [No Abstract]   [Full Text] [Related]  

  • 57. Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.
    Leonard HL; Swedo SE; Rapoport JL; Koby EV; Lenane MC; Cheslow DL; Hamburger SD
    Arch Gen Psychiatry; 1989 Dec; 46(12):1088-92. PubMed ID: 2686576
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lithium and tryptophan augmentation in clomipramine-resistant obsessive-compulsive disorder.
    Rasmussen SA
    Am J Psychiatry; 1984 Oct; 141(10):1283-5. PubMed ID: 6435460
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis.
    Ananth J; Pecknold JC; van den Steen N; Engelsmann F
    Prog Neuropsychopharmacol; 1981; 5(3):257-62. PubMed ID: 7022517
    [No Abstract]   [Full Text] [Related]  

  • 60. Biochemical changes during clomipramine treatment of childhood obsessive-compulsive disorder.
    Flament MF; Rapoport JL; Murphy DL; Berg CJ; Lake CR
    Arch Gen Psychiatry; 1987 Mar; 44(3):219-25. PubMed ID: 3548637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.